Sifuvirtide,a Fusion Inhibitor Against HIV

来源 :2006中国天津世界艾滋病日科技会议 | 被引量 : 0次 | 上传用户:hwcf
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  FusoGen Pharmaceuticals,Inc.is a leading Chinese biotech company based in Tianjin and Beijing,China.The company was founded in 2002 by Jason G.Zhou,an expert in structural biology and computer-assisted drug design.FusoGen is dedicated to the discovery and development of novel therapeutics for serious virus infections,such as AIDS and Hepatitis B.
其他文献
会议
会议
会议
会议
会议
会议
会议
会议
会议
Viruses,by definition,are obligate intracellular pathogens and therefore,successful vaccination must induce cellmediated immunity for effective control and/or prevention of disease.Since HIV-1 is pred
会议